Browsing: Genitourinary

Top Line: Is there an effective adjunct systemic therapy regimen for cisplatin-ineligible patients choosing definitive surgery for muscle-invasive bladder cancer…

Top Line: Determining the ideal fractionation scheme for definitive stereotactic ablative radiation (SABR) for renal cell carcinoma (RCC) depends largely…

Top Line: Is molecular residual disease ready to guide management following cystectomy?The Study: Liquid biopsy–based ctDNA testing has emerged as…

Top Line: Pelvic recurrence of bladder cancer can cause significant morbidity even if distant disease is a main driver of…

This editorial suggests those claiming modern peri- and neoadjuvant therapy for muscle-invasive bladder cancer elevates bladder preservation from “promising alternative”…

Top Line: Do you cover elective nodes for bladder cancer?The Study: On the one hand, many historic large cooperative group…

Headline: Adjuvant radiation improves outcomes for patients with locally advanced bladder cancer. The Study: We’ve previously seen favorable toxicity results…

A large systematic review reports robust evidence for the use of ablative radiation for renal cell carcinoma primary tumors across…

A cost-effectiveness analysis! demonstrates radical cystectomy versus organ-preserving trimodality therapy result in virtually identical amount of quality-adjusted life years, with…

A retrospective look at 121 patients receiving SBRT near the ureters reveals a quarter of plans (n=32) exceeded a commonly…